P667 Benefit of 5-ASA continuation on UC disease outcomes following initiation of a biologic
Tomasic, V, Biscanin, A, Cacic, P, Babic, F, Burcul, I, Dorosulic, Z, Kralj, D, Ogresta Kordej, D, Hrabar, D
Published in Journal of Crohn's and colitis (24.01.2024)
Published in Journal of Crohn's and colitis (24.01.2024)
Get full text
Journal Article
P565 Comparison of the efficacy of adalimumab and ustekinumab for prevention of intestinal fibrosis in bio-naive Crohn's Disease patients
Biscanin, A, Tomašić, V, Babic, F, Ćaćić, P, Ogresta Kordej, D, Hrabar, D, Kralj, D, Dorosulić, Z
Published in Journal of Crohn's and colitis (30.01.2023)
Published in Journal of Crohn's and colitis (30.01.2023)
Get full text
Journal Article
P340 The association between colon pseudopolyps presence and clinical adverse events in UC patients treated with biologics
Tomasic, V, Biscanin, A, Cacic, P, Babic, F, Burcul, I, Siranovic Pongrac, I, Kralj, D, Dorosulic, Z, Ogresta Kordej, D, Hrabar, D
Published in Journal of Crohn's and colitis (24.01.2024)
Published in Journal of Crohn's and colitis (24.01.2024)
Get full text
Journal Article